Literature DB >> 35933187

Pituitary apoplexy after COVID-19 vaccination: Correspondence.

Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35933187      PMCID: PMC9296681          DOI: 10.1016/j.medcli.2022.06.008

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   3.200


× No keyword cloud information.
Dear Editor: We would like to share ideas on “Case report: Pituitary apoplexy after COVID-19 vaccination.” Pituitary apoplexy following COVID-19 vaccination was noted as a potential link by Piar-Gutiérrez et al. in a case report. Although the COVID-19 vaccination is beneficial, we are all concerned that it could also be harmful. Pituitary apoplexy, vaccination participants in the current trial could have adverse effects. However, as there is no pre-vaccination data on the health and immunological status of vaccine recipients, no inferences can be drawn. The issue could have its roots in a patient comorbidity. Co-infections may occur in vaccine recipients following immunization, which is mistakenly thought to be a negative outcome. Pituitary apoplexy, for instance, can develop simultaneously with dengue fever.
  3 in total

1.  Case report: Pituitary apoplexy after COVID-19 vaccination.

Authors:  Ana Piñar-Gutiérrez; Pablo Remón-Ruiz; Alfonso Soto-Moreno
Journal:  Med Clin (Engl Ed)       Date:  2022-06-09

2.  A Rare Case of Pituitary Apoplexy Secondary to Dengue Fever-induced Thrombocytopenia.

Authors:  Mathew Thomas; Alex Robert; Pavan Rajole; Priya Robert
Journal:  Cureus       Date:  2019-08-05
  3 in total
  1 in total

1.  Reply.

Authors:  Ana Piñar-Gutiérrez; Pablo Remón-Ruiz; Alfonso Soto-Moreno
Journal:  Med Clin (Barc)       Date:  2022-06-05       Impact factor: 3.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.